Form 4 holding
SVP and Chief Development Off.
CUMBERLAND PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 129,618
- Estimated value
- $220,351
- Report date
- 31 May 2022
- Price
- $1.70
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|